Complications of Ethanol-amine Oleate Intralesional Sclerotherapy

NCT04930952 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 15

Last updated 2026-05-13

No results posted yet for this study

Summary

The aim of this study is to clarify complications of Ethanolamine Oleate intralesional injections of maxillofacial venous formations in pediatric patients

Conditions

  • Venous Malformation

Interventions

DRUG

Ethanol-amine Oleate Sclerotherapy Injection

Intralesional Sclerotherapy Injection

Sponsors & Collaborators

  • Suez Canal University

    lead OTHER

Principal Investigators

  • Sarah Arafat, MSc · Assistant Lecturer

Eligibility

Max Age
12 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-02-28
Primary Completion
2021-02-28
Completion
2021-03-03

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04930952 on ClinicalTrials.gov